Setting-up of a 24 h model to evaluate the activity of antibiotics against intracellular forms of S. aureus infection C. Seral, M. Barcia-Macay, F. Van.

Slides:



Advertisements
Similar presentations
5/20/2015ISAP Is the cellular accumulation of antibiotics a predictive factor for intracellular efficacy ? Sandrine Lemaire Université catholique.
Advertisements

25 MB of information … CONTENT OF THE CD-rom Learning appropriate use of antibiotics (PK/PD and guidelines): a CD-rom course for healthcare professionals.
PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
MACROLIDES: pharmacokinetics and pharmacodynamics
Antibiotic combinations vs. monotherapy in critical care
Hunting intracellular bacteria with antibiotics
Bacterial persistence
Setting-up a model of intracellular infection by Pseudomonas aeruginosa for the pharmacodynamic evaluation of antibiotic activity. J. Buyck1, O. Jolois2,
studies with Caco-2 cells and THP-1 macrophages
Activities of Daptomycin (DAP), Vancomycin (VAN) and Linezolid (LDZ) alone or in combination with Fusidic acid (FUS) in an in vitro dynamic model of.
Activity of tobramycin in combination with clarithromycin
Introduction Results Aim of the study Methods References Conclusion
International Society for Anti-infective Pharmacology (ISAP)
Intracellular Infection of THP-1 Human Macrophages by Staphylococcus aureus and Role of Haemolysins Mailling adresse: Aurélie Olivier.
Antifungal activity (MIC/MFC) against Candida spp.
Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring.
Intracellular antibiotics and Listeria monocytogenes
Françoise Van Bambeke & Paul M. Tulkens
In vitro pharmacodynamic models for the study of antibiotic activity against bacterial biofilms Françoise Van Bambeke, PharmD, PhD Pharmacologie cellulaire.
Frédéric Peyrusson, Françoise Van Bambeke, Paul M. Tulkens
Activity of 9 antibiotics against intracellular forms of S. pneumoniae
P1058 Intracellular activity of antibiotics against a stable small colony variant (SCV) isolated from a CF patient in a model Calu-3 human airway epithelial.
Pharmacokinetics of Old and New Glycopeptides
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.
Revealing moxifloxacin activity against biofilms of S
FUS, VAN and LZD injected twice (T0 and T12); DAP injected once (T0).
This poster will be made available for download after the meeting at :
Université catholique de Louvain
Introduction Results Aim Methods References Conclusion
Background and objectives
Aminoglycoside nephrotoxicity: from molecular pharmacology and pathology to some applications Paul M. Tulkens, MD, PhD Unité de Pharmacologie Cellulaire.
Activity and Pharmacodynamic (PD) Evaluation of Ceftazidime-Avibactam (CAZ-AVI) against Extracellular and Intracellular Forms of CAZ-susceptible and CAZ-resistant.
Université catholique de Louvain, Brussels, Belgium
Emilien Drouot, Paul M. Tulkens, Françoise Van Bambeke
Julien Buyck, Paul M. Tulkens and Françoise Van Bambeke
Antibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria Françoise Van Bambeke on behalf of J.M. Michot,
Cellular GEN content in electroporated vs. incubated cells.
Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? Visée C.1, Frippiat F1, Descy J.2, Meex C.2, Melin P.2,
Extracellular activity Intracellular activity
Antibiotics in bone and joint infections
Abstract Results Methods Background Conclusions References
UCL Université catholique de Louvain
cellular accumulation (24h) Cstatic (LZD/RDZ ratio)
Apoptosis induced by aminoglycosides (AGs) in cultured cells : comparison between gentamicin (GEN) and amikacin (AMK) using incubated and electroporated.
The machine and its calibration
Incubation (with antibiotic)
52 - Antimicrobials Radezolid (RX-1741), a Novel Oxazolidinone, Accumulates Extensively within Human Macrophages and PMNs and Shows Activity towards.
Of a Pig-related ST-398 Methicillin-Resistant S. aureus (A-MRSA)
EV0626 Cellular pharmacokinetics of gepotidacin (GSK )
A-045 Identification of the Efflux Transporter of Ciprofloxacin in Murine Macrophages: Studies with Ciprofloxacin-Resistant Cells Béatrice Marquez, Nancy.
Abstract Results Aim of the study Methods Background Conclusions
Antibiotic activity of new penams (6-APA) and cephems (7-ACA)
Difference log CFU from time 0
DISCUSSION AND CONCLUSION
Electron microscopy: intracellular infection of THP-1 by S. aureus
Log extracellular concentration (mg/L)
Activity of Moxifloxacin against Staphylococcus aureus in Models of Persistent Infections (Intracellular Survival, Biofilms) Mailing address: P.M. Tulkens.
F. Van Bambeke & P.M. Tulkens
M.P. Mingeot-Leclercq, P.M. Tulkens, F. Van Bambeke
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Intracellular antibiotics
Françoise Van Bambeke, Dr Sc. Pharm, Agr. Ens. Sup.
Intracellular models of infection to evaluate antibiotic activity
Models of Intracellular Antibiotic Transport
Chemotherapy and PK/PD of intracellular infections
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Pharmacodynamic indices in targeting therapy of critical infections
Are intracellular drug concentrations relevant for efficacy
Université catholique de Louvain, Brussels, Belgium
Presentation transcript:

Setting-up of a 24 h model to evaluate the activity of antibiotics against intracellular forms of S. aureus infection C. Seral, M. Barcia-Macay, F. Van Bambeke, M.P. Mingeot-Leclercq, P.M. Tulkens Unité de Pharmacologie cellulaire et moléculaire Université catholique de Louvain Brussels, Belgium

Why intracellular S. aureus ? facultative intracellular organism macrophages, monocytes, PMN endothelial cells … remains hidden for prolonged periods is supposedly protected against many antibiotics exposed to concentrations that do not allow fast killing… is in a metabolic situation that make less susceptible to antibiotics may be a cause of reccurence / resistance !!

Setting-up of the model : J774 mouse macrophages infection of macrophages (0.5 bact/cell) washing with gentamicin 50 µg/ml incubation for up to 24 h with gentamicin 0.5 µg/ml (MIC) for controls antibiotic under study alone for tests  the AB must be able to cope with both extracell. and intracell. S. aureus !!) at clinically-meaningfull concentrations (MIC to Cmax) data from Seral et al. AAC 2003 47:2283-2292

Validation of the model : confocal microscopy 5 hours infection no antibiotic gentamicin 0.5 mg/L data from Seral et al. AAC 2003 47:2283-2292

Validation of the model : electron microscopy

Validation of the model : S. aureus growth in controls

Use of the model to test antibiotic intracellular activity adapted from Seral et al. AAC 2003 47:2283-2292

An improved model : THP-1 human macrophages behavior ~ as human monocytes valuable model for AB activity testing cytokine effect testing infection of macrophages (4 bact/cell) washing with GEN 50 µg/ml incubation for up to 24 h with GEN 0.5 µg/ml (MIC) antibiotic under study 0 h 24 h Auwerx, Experientia, 1990 47:22-31

Aminoglycoside activity : concentration-effect relation for gentamicin highly bactericidal concentr. dependent Poorly bactericidal concentr. independent

Beta-lactam activity : concentration-effect relation for oxacillin More slowly bactericidal concentr. independent slowly acting concentr. dependent

Beta-lactam activity : concentration-effect relation for oxacillin and relation to clinical dosings Intracellular (?) -lactams are concentration-dependent down to 2 log killing !! 400 X MIC !

Quinolone activity : concentration-effect relation for moxifloxacin bactericidal concentr. dependent but more slowly acting and limited to 2-3 log

Quinolone activity at Cmax MIC (ug/ml) 0.06 <0.03 0.125 0.125 Cmax (ug/ml) 4 4 4 4.3 Accumulation 8 9 7 5

Oritavancin : concentration-effect relationships highly bactericidal concentr. dependent more slowly acting but still bactericidal and concentr. dependent

Comparison vancomycin - oritavancin Slowly cidal extracellularly mostly static intracellularly Rapidly cidal extracellularly; More slowly but still cidal intracellularly at 24h

PK – PD parameters predictive of intracellular activity: a global view And we know since 1993 that Synercid accumulates in cells ... adapted from Carryn et al 2003, Infect Dis Clin N Am

And here is the team…. Maritza Cristina Barcia-Macay Seral Marie-Paule Mingeot-Leclercq Paul M. Tulkens Françoise Van Bambeke visit www.antiinfectieux.org And visit also the ISAP web site: www.isap.org